FAM103A1 Activators
FAM103A1 Activators encompass a range of chemical compounds that serve to enhance the functional activity of FAM103A1 through various cellular signaling pathways. Forskolin, through its action of directly stimulating adenylate cyclase, leads to higher intracellular levels of cAMP, which are known to activate PKA. The activation of PKA could result in the phosphorylation and subsequent activation of FAM103A1. Similarly, PMA, acting as an activator of PKC, and Ionomycin, increasing intracellular calcium levels, can activate downstream kinases that may phosphorylate and enhance the activity of FAM103A1. The influence of phosphatase inhibitors such as Calyculin A and Okadaic acid also contributes to the activation of FAM103A1 by preventing the dephosphorylation of this protein, thereby maintaining its activated state. Anisomycin, though a protein synthesis inhibitor, can engage stress-activated protein kinases which could lead to enhanced phosphorylation of FAM103A1, while EGCG may dampen competitive kinase activity, indirectly favoring FAM103A1 activation.
Further contributing to the activation of FAM103A1 are bioactive molecules like Sphingosine-1-phosphate, which through receptor-mediated signaling could modulate activity within the FAM103A1 pathway. The cAMP analog db-cAMP also promotes FAM103A1 activity by activating PKA, which is likely to phosphorylate targets within the FAM103A1 signaling network. Staurosporine, despite its broad kinase inhibitory effects, could selectively relieve negative phosphorylation controls on FAM103A1, inadvertently resulting in its activation. Thapsigargin and LY294002 manipulate intracellular calcium levels and PI3K-dependent signaling, respectively, with both having the potential to enhance FAM103A1 activity through changes in kinase-mediated phosphorylation dynamics. These activators collectively contribute to a multifaceted regulatory environment that, through a cascade of phosphorylation events, augments the functional activity of FAM103A1 without necessitating upregulation at the transcriptional or translational levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diester of phorbol and functions as a potent activator of protein kinase C (PKC). Activation of PKC has been linked to the phosphorylation of proteins that interact with FAM103A1, potentially increasing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium can activate calcium-dependent protein kinases, which may lead to the phosphorylation and activation of FAM103A1. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins. This can result in the enhancement of FAM103A1 activity due to reduced dephosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases, particularly phosphatase 2A. Inhibition of dephosphorylation can lead to the maintained activation state of FAM103A1 due to persistent phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a pyrrolidine antibiotic that acts as a protein synthesis inhibitor and also activates stress-activated protein kinases (SAPKs). Activation of SAPKs may lead to phosphorylation events that enhance FAM103A1 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea with antioxidant properties. It has been shown to inhibit certain protein kinases, which might reduce competitive phosphorylation, thereby potentially enhancing FAM103A1 activity through indirect mechanisms. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, leading to downstream signaling that can influence phosphorylation status and activity in a variety of proteins, possibly including FAM103A1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA-mediated phosphorylation pathways could influence FAM103A1 activity by phosphorylating proteins in the FAM103A1 signaling network. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases. While it generally inhibits kinase activity, the specific inhibition of certain kinases might relieve negative regulation on FAM103A1, indirectly leading to its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sesquiterpene lactone that inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels, which can activate calcium-dependent signaling pathways, possibly enhancing FAM103A1 activity. | ||||||